Nine planned sales by CEO-linked trusts at United Therapeutics (UTHR) total 1,960 shares.
Alpha Vantage · Stock Titan · · AI-summarised by FinFlash
Family trusts associated with Martine A. Rothblatt, Chairperson and CEO of United Therapeutics (UTHR), sold a total of 1,960 common shares across nine transactions on November 5, 2026. These sales were executed as part of a pre-arranged Rule 10b5-1 trading plan adopted in November 2025. Following these transactions, Martine A. Rothblatt directly holds 40,513 common shares.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.